Life Sciences

FOCUS Investment Banking Represents Tectrol in Business Sale

Tectrol has been acquired by CUI Global

Washington, DC (March 13, 2015) – FOCUS Investment Banking, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services announced today that Tectrol, Inc. has been acquired by CUI Global, Inc. (NASDAQ:CUI).  FOCUS represented Tectrol in the transaction.

Tectrol, a family-owned, Toronto, Canada based company, founded in 1968 is a …

FOCUS Investment Banking Represents Medvance Ltd. in Acquisition by NAMSA FOCUS closes another international deal in the healthcare industry

Medvance (Selby, England) has been acquired by NAMSA (Northwood, Ohio).

Washington, DC (January 7, 2014) FOCUS, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that its client, Medvance Ltd., has been acquired by NAMSA. FOCUS represented Medvance in the transaction, adding another international deal to its list of completed 2013 transactions.

Medvance, based in Yorkshire, England, is …

Middle Market Investment Banking Firm, FOCUS LLC, Represents Pleiad in Acquisition by CROMSOURCE International Transaction in Life Sciences and Clinical Research Organization Industry

Pleiad Devices, Ltd. (Stirling, Scotland) has been acquired by Cromsource SRL (Verona, Italy).

Washington, DC (June 4, 2012) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that Pleiad, domiciled in Stirling,Scotland, with a substantial presence in the U.S. (Cambridge, Massachusetts) has been acquired by CROMSOURCE, headquartered in Verona, Italy. FOCUS represented Pleiad in the transaction.

Launched in …

Middle Market Investment Banking Firm FOCUS LLC Represents the Bioline Group of Companies in its Sale to Meridian Bioscience, Inc. Deal Marks Tenth Deal for FOCUS in 2010

Bioline has been acquired by Meridian Bioscience, Inc.

Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.

The acquisition included the purchase of all the outstanding …